These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 12209643

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Identification of human antitumor cytotoxic T lymphocytes epitopes of recoverin, a cancer-associated retinopathy antigen, possibly related with a better prognosis in a paraneoplastic syndrome.
    Maeda A, Ohguro H, Nabeta Y, Hirohashi Y, Sahara H, Maeda T, Wada Y, Sato T, Yun C, Nishimura Y, Torigoe T, Kuroki Y, Sato N.
    Eur J Immunol; 2001 Feb; 31(2):563-72. PubMed ID: 11180121
    [Abstract] [Full Text] [Related]

  • 4. Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation.
    Ohguro H, Ogawa K, Maeda T, Maruyama I, Maeda A, Takano Y, Nakazawa M.
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2589-95. PubMed ID: 11581204
    [Abstract] [Full Text] [Related]

  • 5. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo.
    Ohguro H, Ogawa K, Maeda T, Maeda A, Maruyama I.
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3160-7. PubMed ID: 10586938
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cancer-associated retinopathy vs recoverin-associated retinopathy.
    Keltner JL, Thirkill CE.
    Am J Ophthalmol; 1998 Aug; 126(2):296-302. PubMed ID: 9727525
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease.
    Whitcup SM, Vistica BP, Milam AH, Nussenblatt RB, Gery I.
    Am J Ophthalmol; 1998 Aug; 126(2):230-7. PubMed ID: 9727517
    [Abstract] [Full Text] [Related]

  • 12. Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy.
    Ohguro H, Ogawa K, Nakagawa T.
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):82-9. PubMed ID: 9888430
    [Abstract] [Full Text] [Related]

  • 13. The cancer-associated retinopathy antigen is a recoverin-like protein.
    Thirkill CE, Tait RC, Tyler NK, Roth AM, Keltner JL.
    Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2768-72. PubMed ID: 1388144
    [Abstract] [Full Text] [Related]

  • 14. [Paraneoplastic retinopathy in 2 patients with breast carcinoma].
    Huober J, Holz FG, Schmid H, Nölle B, Bellmann C, Krastel H, Wallwiener D, Bastert G.
    Zentralbl Gynakol; 1997 Sep; 119(6):278-81. PubMed ID: 9312964
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cancer-associated retinopathy syndrome: a case of small cell lung cancer expressing recoverin immunoreactivity.
    Matsubara S, Yamaji Y, Fujita T, Kanayama T, Yamadori I, Sato M, Fujita J, Shiotani T, Takahara J.
    Lung Cancer; 1996 Jun; 14(2-3):265-71. PubMed ID: 8794409
    [Abstract] [Full Text] [Related]

  • 18. Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy.
    Adamus G.
    Autoimmun Rev; 2003 Mar; 2(2):63-8. PubMed ID: 12848960
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-term persistence of antirecoverin antibodies in endometrial cancer-associated retinopathy.
    Adamus G, Amundson D, MacKay C, Gouras P.
    Arch Ophthalmol; 1998 Feb; 116(2):251-3. PubMed ID: 9488286
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.